These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 26494142)
1. Next-generation sequencing and empowering personalised cancer medicine. McDermott U Drug Discov Today; 2015 Dec; 20(12):1470-5. PubMed ID: 26494142 [TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis. Mardis E; Raison C Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041 [TBL] [Abstract][Full Text] [Related]
4. An Overview of DNA Analytical Methods. Arboleda VA; Xian RR Methods Mol Biol; 2019; 1897():385-402. PubMed ID: 30539459 [TBL] [Abstract][Full Text] [Related]
5. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine]. Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology. Sheikine Y; Kuo FC; Lindeman NI J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627 [TBL] [Abstract][Full Text] [Related]
7. Precision medicine for cancer with next-generation functional diagnostics. Friedman AA; Letai A; Fisher DE; Flaherty KT Nat Rev Cancer; 2015 Dec; 15(12):747-56. PubMed ID: 26536825 [TBL] [Abstract][Full Text] [Related]
8. Enabling Precision Oncology Through Precision Diagnostics. Brown NA; Elenitoba-Johnson KSJ Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297 [TBL] [Abstract][Full Text] [Related]
9. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725 [TBL] [Abstract][Full Text] [Related]
10. Clinical Applications of Next-Generation Sequencing. Rebollar-Vega RG; Arriaga-Canon C; de la Rosa-Velázquez IA Rev Invest Clin; 2018; 70(4):153-157. PubMed ID: 30067721 [TBL] [Abstract][Full Text] [Related]
11. Microarray and next-generation sequencing to analyse gastric cancer. Dang Y; Wang YC; Huang QJ Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980 [TBL] [Abstract][Full Text] [Related]
12. Next generation sequencing: implications in personalized medicine and pharmacogenomics. Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891 [TBL] [Abstract][Full Text] [Related]
13. (Cyto)pathology and sequencing: Next (or last) generation? Di Lorito A; Schmitt FC Diagn Cytopathol; 2012 May; 40(5):459-61. PubMed ID: 21538954 [No Abstract] [Full Text] [Related]
14. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream. Mack SC; Northcott PA J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705 [TBL] [Abstract][Full Text] [Related]
15. Personalized Medicine: Genomics Trials in Oncology. Hayes DF; Schott AF Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667 [TBL] [Abstract][Full Text] [Related]
16. The rise of the genome and personalised medicine. Brittain HK; Scott R; Thomas E Clin Med (Lond); 2017 Dec; 17(6):545-551. PubMed ID: 29196356 [TBL] [Abstract][Full Text] [Related]
17. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data. Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559 [TBL] [Abstract][Full Text] [Related]
18. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study. Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119 [TBL] [Abstract][Full Text] [Related]
19. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Syn NL; Yong WP; Goh BC; Lee SC Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175 [TBL] [Abstract][Full Text] [Related]
20. Advancements in Next-Generation Sequencing. Levy SE; Myers RM Annu Rev Genomics Hum Genet; 2016 Aug; 17():95-115. PubMed ID: 27362342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]